|United States Military Academy, MS||1974|
Patrick A. McBrayer is President and Chief Executive Officer of AxioMed™ Spine Corporation of Garfield Heights, Ohio. AxioMed is a medical device company focused on restoring the native function of the spine.
Prior to AxioMed, Mr. McBrayer was Chief Executive Officer of Xylos Corporation, a medical biomaterials company. He is also a Founder of Transave Inc., a biotechnology company focused on the site specific treatment of lung disease. Prior to joining Xylos, Mr. McBrayer served as President and CEO of Exogen, Inc., a company focused on the non-invasive treatment of musculoskeletal injury and disease, which was acquired by Smith & Nephew, Inc. in 1999.
Previously, Mr. McBrayer was President and CEO of Osteotech, Inc., a worldwide leader in tissue technology. In both companies he was responsible for a number of private placements and both companies public offerings and led these organizations to dominant market share positions. He received the Thomas Alva Edison Patent Award in 1998 for a biological implant for bone repair that is now a market leading product. Prior to joining Osteotech, Mr. McBrayer held positions of increasing responsibility for Johnson & Johnson, Inc.
He has over 20 years healthcare senior management experience and served as an Infantry Officer Company Commander in the U.S. Army prior to beginning his business career.
A 1974 graduate of the United States Military Academy, Mr. McBrayer also served on West Point’s Association of Graduates Board of Trustees.